Xponance, Inc. Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Xponance, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 24, 2022	BUY	$144.95 - $152.29 $24,061 - $25,280	166 Added 4.92%	3,542 $535,000
Q2 2022 Aug 02, 2022	BUY	$83.14 - $145.99 $61,191 - $107,448	736 Added 27.88%	3,376 $492,000
Q1 2022 Apr 20, 2022	BUY	$110.08 - $142.92 $2,311 - $3,001	21 Added 0.8%	2,640 $313,000
Q4 2021 Jan 31, 2022	BUY	$99.73 - $148.48 $99 - $148	1 Added 0.04%	2,619 $361,000
Q3 2021 Nov 05, 2021	SELL	$98.85 - $138.91 $33,707 - $47,368	-341 Reduced 11.52%	2,618 $364,000
Q2 2021 Aug 12, 2021	BUY	$65.78 - $105.02 $194,643 - $310,754	2,959 New	2,959 $287,000

792K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $2.8B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Xponance, Inc., based on Form 13F filings with the SEC.

Stay updated on Xponance, Inc. with notifications on news.